EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome

Saja Fadila, Bertrand Beucher, Iria González Dopeso-Reyes, Anat Mavashov, Marina Brusel, Karen Anderson, Caroline Ismeurt, Ethan M Goldberg, Ana Ricobaraza, Ruben Hernandez-Alcoceba, Eric J Kremer, Moran Rubinstein

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci159316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Saja Fadila und 11 weiteren Autor:innen. Beteiligte Einrichtung: Goldschleger Eye Research Institute, and. Hauptthemen laut MEDLINE: NAV1.1 Voltage-Gated Sodium Channel, Epilepsies, Myoclonic. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: E-Rare, The Spanish Dravet Syndrome Foundation, The American Dravet Syndrome Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.1 Voltage-Gated Sodium ChannelEpilepsies, MyoclonicMiceAnimalsSeizuresHippocampusMutation

Stichwörter der Autor:innen

EpilepsyGene therapyNeurodevelopmentNeuroscienceTherapeutics

Substanzen

NAV1.1 Voltage-Gated Sodium Channel

Autor:innen und Institutionen

  • Goldschleger Eye Research Institute, and.
  • Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Institut de Génétique Moléculaire de Montpellier, and.
  • PVM, BioCampus, CNRS, INSERM, University of Montpellier, Montpellier, France.
  • Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
  • Division of Neurology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Förderung

  • E-Rare
  • The Spanish Dravet Syndrome Foundation
  • The American Dravet Syndrome Foundation
  • ANR
  • Fondation pour la Recherche Médicale
  • The Yoran Institute for Human Genome Research at Tel Aviv University
  • Israel Science Foundation

Zitieren

APA

Fadila, S., Beucher, B., Dopeso-Reyes, I. G., Mavashov, A., Brusel, M., Anderson, K., Ismeurt, C., Goldberg, E. M., Ricobaraza, A., Hernandez-Alcoceba, R., Kremer, E. J., & Rubinstein, M. (2023). Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome. Journal of Clinical Investigation. https://doi.org/10.1172/jci159316

Vancouver

Fadila S, Beucher B, Dopeso-Reyes IG, Mavashov A, Brusel M, Anderson K, et al. Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome. Journal of Clinical Investigation. 2023. doi:10.1172/jci159316

BibTeX
@article{Fadila2023,
  author = {Fadila, Saja and Beucher, Bertrand and Dopeso-Reyes, Iria González and Mavashov, Anat and Brusel, Marina and Anderson, Karen and Ismeurt, Caroline and Goldberg, Ethan M and Ricobaraza, Ana and Hernandez-Alcoceba, Ruben and Kremer, Eric J and Rubinstein, Moran},
  title = {Viral vector–mediated expression of NaV1.1, after seizure onset, reduces epilepsy in mice with Dravet syndrome},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci159316}
}
Kostenlos starten →